fda semaglutide shortage resolved 2025 announcement over An update from hims/hers: Compounded semaglutide prescriptions through them are not affected by the semaglutide shortage ISPOR 2025: Exploring reasons for – FDA says shortage of Ozempic

People using GLP-1 medications for type 2 diabetes management often require longer treatment durations than those using them solely for weight loss

30 PKA then promotes the synthesis of insulin peptide precursor in beta-pancreatic cells and inhibits the release of glucagon by alpha pancreatic cells

Beyond weight loss alone, semaglutide appears to reduce liver inflammation and improve markers of liver health, suggesting benefits that extend beyond simple caloric restriction

Users often report appearing 5-10 lbs lighter than their actual weight due to the complete absence of subcutaneous water that other compounds cause

BMI 25 to 30 (overweight) People starting in the overweight range can expect moderate but meaningful weight loss